BackNexalin Technology Overview

Nexalin Technology Cost of Revenue

Cost of Revenue analysis for NXL.

Quarterly Cost of Revenue

$1817.00
86.6% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$1.23M
306.76% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)